- Senior Investigator, Thoracic and Gastrointestinal Oncology Branch
David S. Schrump graduated from the University of Connecticut School of Medicine and completed his general surgery residency at the University of Chicago as well as a 3-year research fellowship in Human Cancer Immunology at Memorial Sloan-Kettering Cancer Center. Following completion of his thoracic surgery residency at the University of Michigan in 1993, Dr. Schrump was appointed to the cardiothoracic surgery faculty at M.D. Anderson Cancer Center.In 1997, he was appointed Head of Thoracic Oncology, Surgery Branch, NCI. He received NIH tenure in 2006. He recieved an MBA in Health Services Management from the Carey School of Business, Johns Hopkins Univsersity in 2009. He is a member of the American Association for Thoracic Surgery, Society of Thoracic Surgeons, John Alexander Society, International Association for the Study of Lung Cancer, Society of Clinical Oncologists, and the American Association for Cancer Research.
Academic Articles153
- (2020). Normal mesothelial cell lines newly derived from human pleural biopsy explants. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. 319(4), L652-L660.
- (2020). Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With Mesothelioma. Journal of Thoracic Oncology. 15(3), 457-461.
- (2020). Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1. ONCOGENE. 39(4), 877-890.
- (2019). CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness. JOURNAL OF PATHOLOGY. 250(2), 205-216.
- (2019). Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer. Cancer Immunology Research. 7(4), 534-543.